Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Clinical Trials

Manufacture Clinical Trials

Right for Patients?

| Ellen Sigal

“Right to Try” legislation may have compassion at its heart, but it does not do enough to ensure patient protection.

Manufacture Business Practice

Business-in-Brief

| Stephanie Sutton

After many years of clinical trial failures in Alzheimer’s disease, pharma sees some positive results – although caution is recommended.

Discovery & Development Clinical Trials

Pharma Fiction

| Stephanie Sutton

A new comedy series focuses on pharma and a clinical trial gone wrong.

Discovery & Development Clinical Trials

Positive Results in Alzheimer’s Trial

| Stephanie Sutton

After many years of clinical trial failures in Alzheimer’s disease, pharma sees some positive results – although caution is recommended.

Discovery & Development Clinical Trials

Bringing Alzheimer’s in from the Cold

| Roisin McGuigan

With big pharma seemingly pulling out of the field, what hope remains for novel treatments for Alzheimer’s disease?

Discovery & Development Clinical Trials

What Women Want

| Stephanie Sutton

Women, like men, want good medicines that have been tested in clinical trials involving fair representation of both sexes.

Discovery & Development Clinical Trials

Coping With the Complex Clinical Trial Landscape…

| James Strachan

Valarie Higgins discusses how clinical trials have evolved over the years and the key lessons she has learned while building her career in the industry.

Manufacture Clinical Trials

The Winning Formula

| Adrian Wildfire

We must find ways to better help vaccine manufacturers to fight the flu – and this is why we developed a new challenge agent for H3N2.

Manufacture Clinical Trials

Recognizing Friend from Foe

| Werner Cautreels

New solutions are needed to teach the immune system to recognize biological drugs as partners rather than plunderers.

Business & Regulation Technology and Equipment

Medicina Ex Machina

| Roisin McGuigan

Artificial intelligence could have a huge impact on drug discovery.

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register